Comoros

Reimbursed Care Access

Comoros is a party to international drug‑control treaties and maintains strict national controls over psychotropic and narcotic substances; there is no public reimbursement pathway or established national medical psychedelic program. Ketamine is the only compound with a well‑established recognized medical role (primarily as an anaesthetic) and is widely listed on WHO essential medicine guidance, whereas classic psychedelics (psilocybin, MDMA, DMT, mescaline, ibogaine, 5‑MeO‑DMT, ayahuasca, 2C‑X) and esketamine have no authorized medical reimbursement or formal national access pathways outside of tightly regulated research or criminal prohibitions. The Union of the Comoros is a party to the UN drug control conventions, which forms the baseline for national control measures. [https://treaties.un.org/Pages/ViewDetails.aspx?src=IND&mtdsg_no=VI-16&chapter=6&clang=_en|UN Treaty Collection - Convention on Psychotropic Substances] [https://api.parliament.uk/UKTreaties/4191|Single Convention accession record for Comoros]